These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24297541)

  • 1. Anti-infectious drug repurposing using an integrated chemical genomics and structural systems biology approach.
    Ng C; Hauptman R; Zhang Y; Bourne PE; Xie L
    Pac Symp Biocomput; 2014; ():136-47. PubMed ID: 24297541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Repurposing against Novel Therapeutic Targets in
    Rai S; Shukla S; Scotti L; Mani A
    Curr Med Chem; 2024; 31(38):6272-6287. PubMed ID: 37550911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated virtual screening and drug repurposing strategy for the discovery of new antimalarial drugs against Plasmodium falciparum phosphatidylinositol 3-kinase.
    Verma K; Lahariya AK; Dubey S; Verma AK; Das A; Schneider KA; Bharti PK
    J Cell Biochem; 2021 Oct; 122(10):1326-1336. PubMed ID: 33998049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the genome of Plasmodium falciparum on the drug-like chemical space reveals novel anti-malarial targets and potential drug leads.
    Jensen K; Plichta D; Panagiotou G; Kouskoumvekaki I
    Mol Biosyst; 2012 Jun; 8(6):1678-85. PubMed ID: 22446744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in omics-based methods to identify novel targets for malaria and other parasitic protozoan infections.
    Cowell AN; Winzeler EA
    Genome Med; 2019 Oct; 11(1):63. PubMed ID: 31640748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
    González-Díaz H; Prado-Prado F; Sobarzo-Sánchez E; Haddad M; Maurel Chevalley S; Valentin A; Quetin-Leclercq J; Dea-Ayuela MA; Teresa Gomez-Muños M; Munteanu CR; José Torres-Labandeira J; García-Mera X; Tapia RA; Ubeira FM
    J Theor Biol; 2011 May; 276(1):229-49. PubMed ID: 21277861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Repurposing: A Review of Old and New Antibiotics for the Treatment of Malaria: Identifying Antibiotics with a Fast Onset of Antiplasmodial Action.
    Pessanha de Carvalho L; Kreidenweiss A; Held J
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33921170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing Anticancer Drugs To Tackle Malaria.
    Le Govic Y; Houzé S; Papon N
    ChemMedChem; 2021 Jul; 16(14):2192-2194. PubMed ID: 33931947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can repurposing drugs play a role in malaria control?
    Cooper RA; Kirkman L
    J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34807244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network-based gene prediction for Plasmodium falciparum malaria towards genetics-based drug discovery.
    Chen Y; Xu R
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S9. PubMed ID: 26099491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing of existing therapeutics to combat drug-resistant malaria.
    Yadav K; Shivahare R; Shaham SH; Joshi P; Sharma A; Tripathi R
    Biomed Pharmacother; 2021 Apr; 136():111275. PubMed ID: 33485067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel molecular targets for antimalarial chemotherapy.
    Jana S; Paliwal J
    Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring anti-malarial potential of FDA approved drugs: an in silico approach.
    Ramakrishnan G; Chandra N; Srinivasan N
    Malar J; 2017 Jul; 16(1):290. PubMed ID: 28720135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics and integrated systems biology in Plasmodium falciparum: a path to malaria control and eradication.
    Le Roch KG; Chung DW; Ponts N
    Parasite Immunol; 2012; 34(2-3):50-60. PubMed ID: 21995286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
    Fiscon G; Conte F; Farina L; Paci P
    PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing for antimicrobial discovery.
    Farha MA; Brown ED
    Nat Microbiol; 2019 Apr; 4(4):565-577. PubMed ID: 30833727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in silico strategy for identification of novel drug targets against Plasmodium falciparum.
    Rout S; Patra NP; Mahapatra RK
    Parasitol Res; 2017 Sep; 116(9):2539-2559. PubMed ID: 28755265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic in silico search for target similarity identifies several approved drugs with potential activity against the Plasmodium falciparum apicoplast.
    Bispo NA; Culleton R; Silva LA; Cravo P
    PLoS One; 2013; 8(3):e59288. PubMed ID: 23555651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Drug Discovery based on Genomics, Proteomics and Bioinformatics in Malaria.
    Aggarwal S; Karmakar A; Krishnakumar S; Paul U; Singh A; Banerjee N; Laha N; Roy Ball G; Srivastava S
    Curr Top Med Chem; 2023; 23(7):551-578. PubMed ID: 37073654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.